Hirtle Callaghan & Co LLC - ZIOPHARM ONCOLOGY INC ownership

ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 133 filers reported holding ZIOPHARM ONCOLOGY INC in Q1 2015. The put-call ratio across all filers is 0.78 and the average weighting 0.5%.

Quarter-by-quarter ownership
Hirtle Callaghan & Co LLC ownership history of ZIOPHARM ONCOLOGY INC
ValueSharesWeighting
Q4 2014$16,000
+77.8%
3,2520.0%0.00%
+300.0%
Q3 2014$9,000
-30.8%
3,2520.0%0.00%
-50.0%
Q2 2014$13,000
-7.1%
3,2520.0%0.00%0.0%
Q4 2013$14,000
+180.0%
3,252
+159.7%
0.00%
+100.0%
Q3 2013$5,000
+66.7%
1,2520.0%0.00%
-97.1%
Q2 2013$3,0001,2520.04%
Other shareholders
ZIOPHARM ONCOLOGY INC shareholders Q1 2015
NameSharesValueWeighting ↓
DISCOVERY CAPITAL MANAGEMENT, LLC / CT 14,642,959$25,186,0003.76%
MSD Partners, L.P. 15,151,516$26,061,0002.11%
MSD Partners, L.P. 7,575,758$13,030,0001.05%
MAGNOLIA CAPITAL ADVISORS LLC 418,569$720,0000.61%
STEEL GROVE CAPITAL ADVISORS, LLC 1,080,000$1,858,0000.33%
EAM Investors, LLC 454,625$782,0000.17%
Allred Capital Management, LLC 158,000$271,0000.17%
Boxer Capital, LLC 1,500,000$2,580,0000.14%
GSA CAPITAL PARTNERS LLP 608,037$1,046,0000.14%
CHIRON CAPITAL MANAGEMENT, LLC 116,860$201,0000.14%
View complete list of ZIOPHARM ONCOLOGY INC shareholders